Clinical trial
Tenofovir Exposures in Advanced Kidney Disease Study
NCT07812571
Study timeline
Study start (estimated)2026-11-01Date precision: day
Registry last updated2026-09-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Tenofovirunresolved
Tenofovir Alafenamide Fumarateunresolved
Chronic Kidney Dieaseunresolved
Kidney Failureunresolved
Pharmacokineticsunresolved
Interventions
Plasma sampling for tenofovir and emtricitabineDIAGNOSTIC_TEST
DescovyDRUG · verified · RxNorm: Descovy
Sponsors & collaborators
King's College Hospital NHS Trustlead sponsor
Gilead Sciencescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07812571 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.